Hua Meng
About
In The Last Decade
Hua Meng
19 papers receiving 516 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 309
- Molecular Biology 291
- Health, Toxicology and Mutagenesis 54
- Strategy and Management 32
- Oncology 31
Countries citing papers authored by Hua Meng
This map shows the geographic impact of Hua Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Meng more than expected).
Fields of papers citing papers by Hua Meng
This network shows the impact of papers produced by Hua Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Meng. The network helps show where Hua Meng may publish in the future.
Co-authorship network of co-authors of Hua Meng
This figure shows the co-authorship network connecting the top 25 collaborators of Hua Meng. A scholar is included among the top collaborators of Hua Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Meng. Hua Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 25 | |
| 5 | 17 | |
| 6 | LncRNA SNHG12 promotes the development and progression of colon cancer by regulating the miR-15a/PDK4 axis. | 9 |
| 7 | 21 | |
| 8 | 6 | |
| 9 | 13 | |
| 10 | 17 | |
| 11 | 21 | |
| 12 | 25 | |
| 13 | 3 | |
| 14 | 2 | |
| 15 | 13 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | 38 | |
| 19 | 231 | |
| 20 | [Endostatin in different administration routes combined with adriamycin chemotherapy in the treatment of liver cancer xenograft in mice]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.